27
2
2
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T15550 | IDH-305 | Dehydrogenase | |
IDH-305 is an orally available, mutant-selective and brain-penetrant IDH1 inhibitor. IDH-305 shows greater than 200 fold selectivity for mutant IDH1 isoforms vs. WT (IC50s: 27 nM (IDH1R132H), 28 nM (IDH1R132C), 6.14 µM (... | |||
T2104 | AGI-5198 | IDH-C35 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
AGI-5198 (IDH-C35) is a highly effective and specific inhibitor of IDH1 R132H/R132C mutants (IC50: 0.07/0.16 μM). | |||
T15551 | IDH889 | Dehydrogenase | |
IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt). | |||
T63380 | IDH-C227 | ||
IDH-C227 is a selective and potent inhibitor of IDH1R132H that exhibits anticancer activity. | |||
T16161 | Mutant IDH1 inhibitor | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
Mutant IDH1 inhibitor is an effective inhibitor of mutant IDH1 R132H (IC50: < 72 nM). | |||
T12128 | Mutant IDH1-IN-2 | Isocitrate Dehydrogenase (IDH) | |
Mutant IDH1-IN-2 is a mutant Isocitrate dehydrogenase (IDH) proteins inhibitor | |||
T2043 | Mutant IDH1-IN-1 | IDH1-IN-1 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM. | |||
TQ0042 | BAY-1436032 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1). | |||
T7741 | DS-1001b | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
DS-1001b is an inhibitor of mutant IDH-1 (Isocitrate Dehydrogenase-1) | |||
T1809 | AGI-6780 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant. | |||
T2346 | Enasidenib | AG-221 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Enasidenib (AG-221) is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. | |||
T16384 | Olutasidenib | FT-2102 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Olutasidenib is a highly effective, brain penetrant, and selective inhibitor of the mutant Iso... | |||
T3617 | Ivosidenib | AG-120 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Ivosidenib (AG-120) is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Ivosidenib specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhi... | |||
T7307 | Vorasidenib | PVM/MA,AG-881 | Isocitrate Dehydrogenase (IDH) |
Vorasidenib (PVM/MA) is an inhibitor of mutant isocitrate dehydrogenase (IDH; IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH2R140Q, respectively) | |||
T11611 | IDH1 Inhibitor 2 | Dehydrogenase | |
IDH1 Inhibitor 2 (compound 13) is a potent IDH1 inhibitor via direct covalent modification of His315 (IC50: 110 nM). | |||
T11612 | IDH1 Inhibitor 3 | Others | |
IDH1 Inhibitor 3 is a mutant isocitric dehydrogenase 1 (IDH1) inhibitor (IC50: 45 nM for IDH1R132H). | |||
T11613 | IDH1 Inhibitor 1 | Others | |
IDH1 Inhibitor 1 is an orally bioavailable, brain-penetrant, and selective mutant IDH1 inhibitor (IC50s: 0.021 μM, 0.045 μM, and 2.52 μM for IDH1R132H, IDH1R132C, and IDH1WT). | |||
T12129 | Mutant IDH1-IN-4 | Others | |
Mutant IDH1-IN-4 is an mutant Isocitrate dehydrogenase 1 (IDH 1) inhibitor. | |||
T39716 | Mutant IDH1-IN-6 | Mutant IDH1-IN-6 | |
Mutant IDH1-IN-6 is an orally active compound that effectively inhibits mutant isocitrate dehydrogenase (IDH) enzymes. It demonstrates potency and selectivity, with IC50 values of 6.27, 3.71, 36.9, and 11.5 nM for IDH1 R... | |||
T79745 | IDH2R140Q-IN-2 | Dehydrogenase | |
IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation ... | |||
T63403 | WT IDH1 Inhibitor 2 | ||
WT IDH1 Inhibitor 2 is a wild-type isocitrate dehydrogenase 1 (WT IDH1) inhibitor (IC50: 120 nM) and is a mutant R132H IDH1 inhibitor, an isoform of GSK321 with wild-type cross-reactivity. | |||
T72705 | IDH1 Inhibitor 7 | ||
IDH1 Inhibitor 7 is an IDH1 inhibitor with an IC 50 of less than 100 nM . | |||
T63193 | IDH2R140Q-IN-1 | ||
IDH2R140Q-IN-1 is a potent inhibitor of IDH2R140Q (IC50: 6.1 nM) and can be used in studies of acute myeloid leukemia. | |||
T62725 | IDH1 Inhibitor 5 | ||
IDH1 Inhibitor 5 (compound 2) is an inhibitor of IDH1 (isocitrate dehydrogenase 1), which inhibits MOG cells (IC50: 64.4 nM) and wild-type IDH1 glioma cells expressing exogenous mutant IDH1 R132H protein (IC50: 34.9 nM). | |||
T62698 | MIDH1-IN-1 | ||
mIDH1-IN-1 (compound 43) is a potent and selective inhibitor of mIDH1 (isocitrate dehydrogenase 1 mutant) (IC50: 961.5 nM). mIDH1-IN-1 effectively inhibits the production of 2-HG (2-hydroxyglutarate) in HT1080 cells (EC5... | |||
T78758 | IHMT-IDH1-053 | Isocitrate Dehydrogenase (IDH) | |
IHMT-IDH1-053 (compound 16) is an irreversible inhibitor exhibiting high selectivity for the IDH1 R132H mutant, achieving an IC50 of 4.7 nM. It preferentially targets IDH1 mutants over wild-type IDH1 and IDH2, both wild-... | |||
T63402 | (S,R)-WT IDH1 Inhibitor 2 | ||
(S,R)-WT IDH1 Inhibitor 2 is a selective and potent mutant IDH1 inhibitor that inhibits R132G (IC50: 2.9 nM), R132C (IC50: 3.8 nM), R132H (IC50: 4.6 nM) and WT IDH1 (IC50: 46 nM) with 100-fold higher selectivity than IDH... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T74193 | (R)-IDHP | ||
(R)-IDHP, an isomer of IDHP and a metabolite of salvia, exhibits vasorelaxant properties by inhibiting calcium (Ca 2+) release and inward flow through both voltage-dependent and receptor-operated calcium channels in vasc... | |||
T3682 | (-)-Catechin gallate | (-)-Catechin 3-O-gallate,(-)-Catechin 3-gallate | Others , COX |
(-)-Catechin gallate ((-)-Catechin 3-O-gallate) displays inhibition of 6PGD, IDH. (-)-Catechin gallate ((-)-Catechin 3-O-gallate) displays inhibition of human Beta-secretase. (-)-Catechin gallate ((-)-Catechin 3-O-gallat... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02413 | Isocitrate dehydrogenase/IDH1 Protein, Human, Recombinant (His) | Human | E. coli |
Isocitrate dehydrogenase/IDH1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 48 kDa and the accession number is O75874. | |||
TMPJ-01009 | BLVRA Protein, Human, Recombinant (His) | Human | E. coli |
Human Biliverdin reductase A (BLVRA) is belonged to the Gfo/Idh/MocA family and Biliverdin reductase subfamily. BLVRA is an enzyme that in humans is encoded by the BLVRA gene. BLVRA plays an important role in reducing th... |
Cat No. | Product Name | ||
---|---|---|---|
L2130 | Anti-Cancer Metabolism Compound Library | 1268 compounds | |
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); |